Test Overview
Clinical Utility
This assay is intended for research use only.
Method
Fixed Cell-based Assay (CBA)
Analytical Platform
EUROIMMUN
Result Included
Anti-NF155; Anti-NF186; Anti-CNTN1; Anti-CNTN1/CASPR1
Aliases/Synonyms
Nodal and Paranodal Antibodies; Anti-NF155; Anti-NF186; Anti-CNTN1; Anti-CASPR1; Neurofascin 155; Contactin 1; Contactin Associated Protein 1; Neurofascin 186
Specimen
Specimen Type
SerumImportant Note: TEST ID CIDPLON S
Non-interfaced clients should specify the Test ID CIDPLON S when ordering this test. Not doing so will cause processing delays while ICL ascertains which test you are requesting.
Similar testing is available for clinical use at BC Neuroimmunology Laboratory: Chronic Inflammatory Demyelinating Neuropathy (CIDP) Panel, Serum
Containers
Collection Containers
Gold top (clot activator & gel);Red top (no additive)
Volume
Sample Volume
3.0 mL
Minimum Volume
1.0 mL
Collection & Handling
Handling Information
Store and send cold.
Stability
| Ambient | Refrigerated | Frozen |
|---|---|---|
| 72 hours | 14 days | 30 days |
Performance & Interpretation
Turnaround Time
16 days
Results
-
Anti-NF155 CBANegative
Comment
For Research purposes only, please interpret with caution. LHSC is not accredited for this research test.
-
Anti-NF186 CBANegative
Comment
For Research purposes only, please interpret with caution. LHSC is not accredited for this research test.
-
Anti-CNTN1 CBANegative
Comment
For Research purposes only, please interpret with caution. LHSC is not accredited for this research test.
-
Anti-CNTN1/CASPR1 CBANegative
Comment
For Research purposes only, please interpret with caution. LHSC is not accredited for this research test.
Referral Location
Canada
Interface & Setup
HL7 Interface Codes
| Order Code | Result Name | Result Codes | Units |
|---|---|---|---|
| CIDPLON S | Anti-NF155 CBA, Serum | 65271 | |
| Anti-NF186 CBA, Serum | 65272 | ||
| Anti-CNTN1 CBA, Serum | 65273 | ||
| Anti-CNTN1/CASPR1 CBA, Serum | 65274 | ||
| CIDP Antibody Result | 65296 |
Test Version
Last Updated
2024-07-25